Ex Vivo Lentivirus Transduction and Immediate Transplantation of Uncultured Hepatocytes for Treating Hyperbilirubinemic Gunn Rat

Background. Ex vivo liver gene therapy provides an attractive alternative to orthotopic liver transplantation for the treatment of liver diseases. We previously reported a protocol in which human primary hepatocytes are highly transduced in Suspension with Lentiviral vectors and Immediately Transplanted (SLIT). Here, we evaluated the SLIT approach in Gunn rats, the animal model for Crigler-Najjar syndrome type 1, a defect in bilirubin UDP-glucuronosyltransferase (BUGT). Methods. We constructed lentiviral vectors coding for BUGT under control of an ubiquitous promoter. Control vectors contained Green Fluorescent Protein (GFP) under control of the same promoter. Hepatocytes were isolated from jaundiced Gunn rats and transduced in suspension for four hr. After washing, 2×107 hepatocytes were immediately transplanted into syngeneic rats. Bilirubinemia and bile pigments were regularly assessed after cell transplantation. The percentage and presence of transduced hepatocytes was analyzed by immunohistochemistry in GFP-transplanted animals. Results. In rats receiving BUGT-transduced hepatocytes, bilirubinemia decreased by about 30%. The level of correction remained stable for up to 240 days. Bilirubin glucuronides were present in the bile of treated animals, indicating the metabolic activity of engrafted hepatocytes. In contrast, bilirubinemia in GFP-transplanted rats did not decline but rather increased. GFP-positive hepatocytes amounted to 0.5–1% of the liver, which is in agreement with the number of transplanted and genetically-modified hepatocytes (6×106). Conclusions. This work reports the first demonstration of long-term metabolic benefit after rapid transplantation of ex vivo lentivirally tranduced hepatocytes. Therefore, this study demonstrates the therapeutic proof-of-principle and potential of the SLIT approach for treating inherited metabolic liver diseases.

[1]  D. Trono,et al.  Production and Titration of Lentiviral Vectors , 2006, Current protocols in neuroscience.

[2]  D. Grant,et al.  Adult-to-adult living donor liver transplantation. , 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[3]  Sanjeev Gupta,et al.  Integrin and extracellular matrix interactions regulate engraftment of transplanted hepatocytes in the rat liver. , 2005, Gastroenterology.

[4]  Z. Jia,et al.  Long-term correction of hyperbilirubinemia in the Gunn rat by repeated intravenous delivery of naked plasmid DNA into muscle. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  D. Trono,et al.  Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  Sanjeev Gupta,et al.  Regulation of Hepatocyte Engraftment and Proliferation after Cytotoxic Drug-Induced Perturbation of the Rat Liver , 2005, Transplantation.

[7]  D. Aubert,et al.  Successful gene therapy of the Gunn rat by in vivo neonatal hepatic gene transfer using murine oncoretroviral vectors , 2005, Hepatology.

[8]  D. Trono,et al.  A Simple and Highly Effective Method for the Stable Transduction of Uncultured Porcine Hepatocytes Using Lentiviral Vector , 2005, Cell transplantation.

[9]  李亚明,et al.  Hepatocyte transplantation , 2005 .

[10]  A. Beaudet,et al.  Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Rela,et al.  Hepatocyte transplantation for inherited factor VII deficiency. , 2004, Transplantation.

[12]  N. Ferry,et al.  Liver gene therapy: advances and hurdles , 2004, Gene therapy.

[13]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[14]  Adam Bagg,et al.  Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. , 2003, Molecular genetics and metabolism.

[15]  A. Moser,et al.  Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. , 2003, Transplantation.

[16]  K. Mollier,et al.  A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector , 2003, Hepatology.

[17]  S. Strom,et al.  Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. , 2003, Pediatrics.

[18]  J. Dougherty,et al.  Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors , 2003, Hepatology.

[19]  M. Wiznerowicz,et al.  Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retina , 2003, Gene Therapy.

[20]  J. Prieto,et al.  In vitro and in vivo comparative study of chimeric liver-specific promoters. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  B. Vikram,et al.  A novel strategy for in vivo expansion of transplanted hepatocytes using preparative hepatic irradiation and FasL-induced hepatocellular apoptosis , 2003, Gene Therapy.

[22]  J. Seppen,et al.  Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  T. Berney,et al.  Adult-to-adult living-donor liver transplantation. A summary of current status and an outline of the program in Geneva. , 2003, Swiss surgery = Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera.

[24]  B. Vikram,et al.  Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection , 2002, Hepatology.

[25]  P. Morel,et al.  Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  S. Lee,et al.  A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler–Najjar syndrome , 2002, Gene Therapy.

[27]  F. Ris,et al.  Potential impact of in situ liver splitting on the number of available grafts , 2002, Transplantation.

[28]  A. Granato,et al.  Hepatocyte transplantation as a treatment for glycogen storage disease type 1a , 2002, The Lancet.

[29]  L. Naldini,et al.  Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. , 2002, Human gene therapy.

[30]  D. Strayer,et al.  A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats. , 2000, Gastroenterology.

[31]  Guisheng Zhang,et al.  Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure , 2000, Gene Therapy.

[32]  L. Ailles,et al.  Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences , 2000, Nature Genetics.

[33]  Kan-Hoe Lee,et al.  Whither living donor liver transplantation? , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[34]  Luc Montagnier,et al.  HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap , 2000, Cell.

[35]  D. Trono.  Lentiviral vectors: turning a deadly foe into a therapeutic agent , 2000, Gene Therapy.

[36]  B. Vikram,et al.  Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. , 1999, Cancer research.

[37]  T. Hope,et al.  Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances Expression of Transgenes Delivered by Retroviral Vectors , 1999, Journal of Virology.

[38]  P. Novikoff,et al.  Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium , 1999, Hepatology.

[39]  L. Rubbia‐Brandt,et al.  Improvement of the effect of hepatocyte isograft in the Gunn rat by cotransplantation of islets of Langerhans. , 1999, Journal of pediatric surgery.

[40]  P. Briand,et al.  Amphotropic retroviral vectors displaying hepatocyte growth factor-envelope fusion proteins improve transduction efficiency of primary hepatocytes. , 1998, Human gene therapy.

[41]  P. Bosma,et al.  Long-term amelioration of bilirubin glucuronidation defect in Gunn rats by transplanting genetically modified immortalized autologous hepatocytes. , 1998, Cell transplantation.

[42]  S. Strom,et al.  Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. , 1998, The New England journal of medicine.

[43]  M. Ott,et al.  Oral tolerization to adenoviral proteins permits repeated adenovirus‐mediated gene therapy in rats with pre‐existing immunity to adenoviruses , 1998, Hepatology.

[44]  V. Sandig,et al.  Reactivation of the Previously Silenced Cytomegalovirus Major Immediate-Early Promoter in the Mouse Liver: Involvement of NFκB , 1998, Journal of Virology.

[45]  P. Bosma,et al.  Long-term reduction of serum bilirubin levels in Gunn rats by retroviral gene transfer in vivo. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[46]  J. Roy-Chowdhury,et al.  Transient immunosuppression with FK506 permits long‐term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat , 1997, Hepatology.

[47]  K. Ogawa,et al.  Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans cinnamon rats. , 1996, Gastroenterology.

[48]  M. Horwitz,et al.  Long Term Correction of Bilirubin-UDP-glucuronosyltransferase Deficiency in Gunn Rats by Administration of a Recombinant Adenovirus during the Neonatal Period* , 1996, The Journal of Biological Chemistry.

[49]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[50]  R. M. Hays,et al.  Microtubular Disruption Prolongs the Expression of Human Bilirubin-uridinediphosphoglucuronate-glucuronosyltransferase-1 Gene Transferred into Gunn Rat Livers (*) , 1996, The Journal of Biological Chemistry.

[51]  D. Rader,et al.  A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia , 1995, Nature Medicine.

[52]  F. Askari,et al.  Retrovirus-mediated expression of HUG Br1 in Crigler-Najjar syndrome type I human fibroblasts and correction of the genetic defect in Gunn rat hepatocytes. , 1995, Gene therapy.

[53]  James M. Wilson,et al.  Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia , 1994, Nature Genetics.

[54]  N. Blanckaert,et al.  Liquid-chromatographic assay and identification of mono- and diester conjugates of bilirubin in normal serum. , 1983, Clinical chemistry.